1. Home
  2. TASK vs MYGN Comparison

TASK vs MYGN Comparison

Compare TASK & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TaskUs Inc.

TASK

TaskUs Inc.

HOLD

Current Price

$5.50

Market Cap

544.9M

Sector

Technology

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.32

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TASK
MYGN
Founded
2008
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
544.9M
444.2M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
TASK
MYGN
Price
$5.50
$4.32
Analyst Decision
Hold
Buy
Analyst Count
5
7
Target Price
$14.70
$7.64
AVG Volume (30 Days)
476.9K
1.6M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
120.00
N/A
EPS
0.26
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
$5.95
$6.86
Revenue Next Year
$6.46
$5.45
P/E Ratio
$21.42
N/A
Revenue Growth
N/A
2.33
52 Week Low
$5.37
$3.53
52 Week High
$18.39
$8.59

Technical Indicators

Market Signals
Indicator
TASK
MYGN
Relative Strength Index (RSI) 36.81 49.15
Support Level $5.39 $3.53
Resistance Level $6.62 $5.30
Average True Range (ATR) 0.25 0.32
MACD -0.02 0.06
Stochastic Oscillator 12.00 52.11

Price Performance

Historical Comparison
TASK
MYGN

About TASK TaskUs Inc.

TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: